Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
McEwen Inc
MUX
$1.07B
| $2.72M | ﹤0.01% |
269,227
+307
| +0.1% | +$2.85K |
|
|
ITI
2677
DELISTED
Iteris, Inc.
ITI
| $2.71M | ﹤0.01% |
569,973
+8,712
| +2% | +$36.3K |
|
|
RPT
2678
Rithm Property Trust
RPT
$95.1M
| $2.7M | ﹤0.01% |
48,893
+6,570
| +16% | +$321K |
|
|
IHC
2679
DELISTED
Independence Holding Company
IHC
| $2.7M | ﹤0.01% |
88,162
+2,648
| +3% | +$73.9K |
|
|
KIN
2680
DELISTED
Kindred Biosciences, Inc.
KIN
| $2.69M | ﹤0.01% |
598,787
+59,481
| +11% | +$266K |
|
2681
AXT Inc
AXTI
$4.49B
| $2.68M | ﹤0.01% |
563,409
+39,994
| +8% | +$188K |
|
2682
Berkshire Hathaway Class A
BRK.A
$1.1T
| $2.67M | ﹤0.01% |
10
| – | – |
|
2683
YPF
YPF
$20B
| $2.67M | ﹤0.01% |
467,218
+11,034
| +2% | +$51.5K |
|
2684
Oportun Financial
OPRT
$267M
| $2.67M | ﹤0.01% |
198,336
+93,090
| +88% | +$866K |
|
2685
Spero Therapeutics
SPRO
$66.6M
| $2.66M | ﹤0.01% |
196,700
+41,476
| +27% | +$466K |
|
2686
Acacia Research
ACTG
$447M
| $2.66M | ﹤0.01% |
650,464
-27,826
| -4% | -$80.7K |
|
2687
Boston Omaha
BOC
$437M
| $2.66M | ﹤0.01% |
166,060
+11,966
| +8% | +$200K |
|
2688
Cato Corp
CATO
$69.3M
| $2.64M | ﹤0.01% |
323,328
+6,369
| +2% | +$62.8K |
|
|
MCF
2689
DELISTED
Contango Oil & Gas Co.
MCF
| $2.64M | ﹤0.01% |
1,151,738
+565,157
| +96% | +$1.38M |
|
|
ANH
2690
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $2.64M | ﹤0.01% |
1,550,715
+85,753
| +6% | +$133K |
|
2691
United States Lime & Minerals
USLM
$3.21B
| $2.63M | ﹤0.01% |
155,990
+4,440
| +3% | +$69.3K |
|
|
GTYH
2692
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $2.62M | ﹤0.01% |
629,635
+51,849
| +9% | +$202K |
|
|
GDEN
2693
DELISTED
Golden Entertainment
GDEN
| $2.62M | ﹤0.01% |
293,296
+10,103
| +4% | +$94K |
|
2694
OptimizeRx
OPRX
$123M
| $2.62M | ﹤0.01% |
200,785
+20,212
| +11% | +$220K |
|
2695
Southern Missouri Bancorp
SMBC
$867M
| $2.61M | ﹤0.01% |
107,607
+1,028
| +1% | +$23.8K |
|
|
LBC
2696
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.61M | ﹤0.01% |
261,490
+20,230
| +8% | +$195K |
|
|
CBMG
2697
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.61M | ﹤0.01% |
174,606
+10,410
| +6% | +$149K |
|
|
WTRE
2698
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $2.61M | ﹤0.01% |
156,536
+6,637
| +4% | +$95.1K |
|
2699
National Bankshares
NKSH
$262M
| $2.61M | ﹤0.01% |
91,292
+2,007
| +2% | +$58.4K |
|
2700
Comscore
SCOR
$108M
| $2.61M | ﹤0.01% |
42,054
+3,944
| +10% | +$236K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.